Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 26, 2012, Pages 10492-10497

  Bobr, Aleh ^a   Igyarto, Botond Z ^a   Haley, Krystal M ^a   Li, Ming O ^b   Flavell, Richard A ^c   Kaplan, Daniel H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

pSMAD2 3; Skin immunology; Tolerance

Indexed keywords

CYTOKINE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CELL MIGRATION; CONTROLLED STUDY; INFLAMMATION; LANGERHANS CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; REPORTER GENE; SKIN DISEASE; STEADY STATE; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; CELL MOVEMENT; HOMEOSTASIS; LANGERHANS CELLS; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

MUS;

EID: 84862987203     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1119178109     Document Type: Article

References (32)

1. Romani N, Clausen BE, Stoitzner P (2010) Langerhans cells and more: Langerinexpressing dendritic cell subsets in the skin. Immunol Rev 234:120-141.
2. Hemmi H, et al. (2001) Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int Immunol 13: 695-704. (Pubitemid 32427872)
3. Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8:935-947.
4. Chorro L, et al. (2009) Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med 206:3089-3100.
5. Merad M, et al. (2002) Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3:1135-1141. (Pubitemid 35469697)
6. Ginhoux F, et al. (2006) Langerhans cells arise from monocytes in vivo. Nat Immunol 7: 265-273.
7. Strobl H, et al. (1996) TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol 157:1499-1507. (Pubitemid 126449086)
8. Geissmann F, et al. (1998) Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 187:961-966. (Pubitemid 28141669)
9. Borkowski TA, Letterio JJ, Farr AG, Udey MC (1996) A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 184: 2417-2422. (Pubitemid 27023742)
10. Hacker C, et al. (2003) Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 4:380-386. (Pubitemid 36432322)
11. Fainaru O, et al. (2004) Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 23:969-979. (Pubitemid 38418763)
12. Li MO, Flavell RA (2008) TGF-beta: A master of all T cell trades. Cell 134:392-404.
13. Kaplan DH, et al. (2007) Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med 204:2545-2552. (Pubitemid 350044780)
14. Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE (2010) TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol 185: 3248-3255.
15. Indra AK, et al. (1999) Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27:4324-4327. (Pubitemid 29533170)
16. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ (2005) Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23:611-620. (Pubitemid 41779483)
17. Bobr A, et al. (2010) Acute ablation of Langerhans cells enhances skin immune responses. J Immunol 185:4724-4728.
18. Chytil A, Magnuson MA, Wright CV, Moses HL (2002) Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis 32:73-75. (Pubitemid 34211700)
19. Li MO, Wan YY, Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579-591. (Pubitemid 46756347)
20. Naiki Y, et al. (2005) Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide- induced TLR4 signaling. J Biol Chem 280:5491-5495. (Pubitemid 40280025)
21. Kubo A, Nagao K, Yokouchi M, Sasaki H, AmagaiM (2009) External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 206:2937-2946.
22. Ohtani T, et al. (2009) TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 126:485-499.
23. Kleinridders A, et al. (2009) MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 10: 249-259.
24. Igyártó BZ, et al. (2011) Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35:260-272.
25. Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114:4359-4369. (Pubitemid 34082857)
26. Haley K, et al. (2012) Langerhans cells require MyD88-dependent signals for Candida albicans response but not for contact hypersensitivity or migration. J Immunol 188: 4334-4339.
27. Suzuki E, et al. (2007) A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res 67: 2351-2359. (Pubitemid 46424257)
28. Jiang A, et al. (2007) Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27:610-624. (Pubitemid 47615505)
29. Vander Lugt B, et al. (2011) TGF-β suppresses β-catenin- dependent tolerogenic activation program in dendritic cells. PLoS ONE 6:e20099.
30. Yang Z, et al. (2007) Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol 176:787-793. (Pubitemid 46425539)
31. Kautz-Neu K, et al. (2011) Langerhans cells are negative regulators of the anti- Leishmania response. J Exp Med 208:885-891.
32. Bennett CL, et al. (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. Blood 117:7063-7069.